Skip to main content
Top

Current Gastroenterology Reports

Issue 3/2002

Content (16 Articles)

Invited Commentary

Endoscopic treatment of gastroesophageal reflux disease—fact or fancy?

Jean Paul Galmiche, Jérôme Barouk

Clinical trials report

Reza Shaker, Kulwinder Dua, David Staff

Presbyesophagus: A reappraisal

Kenneth R. DeVault

Esophageal manifestations of dermatologic disease

James L. Wise, Joseph A. Murray

Pharmacologic management of gastroesophageal reflux disease

Amarnath Ramakrishnan, Philip O. Katz

Clinical trials report

Susan R. Orenstein

The surgical management of short bowel syndrome

Edward M. Barksdale Jr, Ala Stanford

New developments in childhood Celiac Disease

Carlo Catassi, Alessio Fasano

Autism and gastrointestinal symptoms

Karoly Horvath, Jay A. Perman

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine